MICHIGAN INSTITUTE FOR NEUROLOGICAL DISORDERS FIRST IN THE COUNTRY TO ADMINISTER NEW FDA-APPROVED ALZHEIMER’S DRUG
First dose of new FDA-approved drug to treat Alzheimer’s disease took place Wednesday, June 16 at the Michigan Institute for Neurological Disorders FARMINGTON HILLS, MI, USA, June 17, 2021 /EINPresswire.com/ -- The first dose of the new FDA-approved …